Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) LT-Debt-to-Total-Asset: 0.04 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605016 Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
96 GF Score
Price ¥21.50
GF Value ¥22.59
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Shandong Bailong Chuangyuan Bio-Tech Co LT-Debt-to-Total-Asset?

Shandong Bailong Chuangyuan Bio-Tech Co SHSE:605016 -9.24% 96 LT-Debt-to-Total-Asset is 0.04 as of Mar. 2026. GuruFocus rates SHSE:605016 with a GF Score™ of 96/100 and a GF Value™ of ¥22.59 (Fairly Valued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shandong Bailong Chuangyuan Bio-Tech Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.04.

Shandong Bailong Chuangyuan Bio-Tech Co's long-term debt to total assets ratio increased from Mar. 2025 (0.00) to Mar. 2026 (0.04). It may suggest that Shandong Bailong Chuangyuan Bio-Tech Co is progressively becoming more dependent on debt to grow their business.

Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shandong Bailong Chuangyuan Bio-Tech Co LT-Debt-to-Total-Asset Related Terms

Shandong Bailong Chuangyuan Bio-Tech Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Bailong Chuangyuan Bio-Tech Co LT-Debt-to-Total-Asset Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.03

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.04 0.03 0.03 0.04
SHSE:605016
96GF Score
Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Bailong Chuangyuan Bio-Tech Co LT-Debt-to-Total-Asset Calculation

Shandong Bailong Chuangyuan Bio-Tech Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=80.005/2436.659
=0.03

Shandong Bailong Chuangyuan Bio-Tech Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=122.864/2799.605
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.04 mean?
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a LT-Debt-to-Total-Asset of 0.04 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors.
Is Shandong Bailong Chuangyuan Bio-Tech Co's LT-Debt-to-Total-Asset too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current LT-Debt-to-Total-Asset is 0.04. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's LT-Debt-to-Total-Asset compare to KHC and GIS?
Shandong Bailong Chuangyuan Bio-Tech Co's LT-Debt-to-Total-Asset of 0.04 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. Shandong Bailong Chuangyuan Bio-Tech Co's current LT-Debt-to-Total-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Fairly Valued. The stock's GF Value™ is ¥22.59, compared to a current price of ¥21.50 — trading 4.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.04. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current LT-Debt-to-Total-Asset is 0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued. The current stock price of ¥21.50 is trading 4.8% below its estimated GF Value™ of ¥22.59. GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Fairly Valued.

Key valuation signals for SHSE:605016:

  • LT-Debt-to-Total-Asset: 0.04
  • GF Value™: ¥22.59 vs. price of ¥21.50 (4.8% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Bailong Chuangyuan Bio-Tech Co Business Description

Address Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
96GF Score

Get the complete analysis for SHSE:605016

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.50
Price
¥22.59
GF Value